Idiopathic Pulmonary Fibrosis
Conditions
Brief summary
The purpose of this study is to create a database of demographics and samples in idiopathic pulmonary fibrosis.
Interventions
None listed
Sponsors
NYU Langone Health
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
1. Male or Female greater or equal to age 18. 2. Referral by physician with the diagnosis of IPF, or interstitial lung disease (IPF considered likely).
Exclusion criteria
(a) Unwilling or unable to give written informed consent.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Determine cellular and molecular determinants of IPF | Long-Term | An IPF Registry is being established to assemble sufficient patients with IPF (especially in its earliest stage) for phase I therapeutic protocols. The Registry will incorporate demographic and clinical data for natural history studies; second, research data on physiology, high-resolution CT scan, questionnaires, and blood samples for blood banking to be collected every 6 months for prospective studies on pathophysiology; and third, response to standard therapies will be monitored to determine cellular and molecular relationships to clinical outcome and predictors of survival. This is done in order to better determine cellular and molecular determinants of IPF. This cohort will be large enough to commence a separate phase I protocol with molecular strategies of intervention. |
Countries
United States
Outcome results
None listed